CryptaCount
EN
EnglishENDeutschDEEspañolESFrançaisFRItalianoIT日本語JA한국어KONederlandsNLPolskiPLPortuguêsPT
Log in Start Free

Injective and BDACS Back a Korean Won Stablecoin for RWA Settlement

CryptaCount Editorial · · 9 min read
AML / KYC / LICENSING Injective and BDACS Back a Korean WonStablecoin for RWA Settlement

A memorandum of understanding signed between the Injective blockchain and South Korean digital-asset infrastructure firm BDACS could push the Korean won into on-chain real-world asset markets for the first time. The deal positions KRW1, BDACS's won-pegged stablecoin, as the exclusive won-denominated settlement asset for tokenized assets on the Injective network, and it arrives at precisely the moment South Korea's lawmakers are finalising a legal framework for domestic stablecoins. For accounting firms, auditors, and CFOs with exposure to Korean institutional clients or cross-border RWA positions, the timing matters.

Injective and BDACS Back a Korean Won Stablecoin for RWA Settlement

What the Partnership Actually Involves

Injective and BDACS signed an MOU that designates KRW1 as the sole won-denominated settlement asset across Injective's on-chain markets. Rather than converting Korean won into dollar-backed stablecoins and then into tokenized assets, counterparties would settle directly in KRW1, removing a currency-conversion step from the transaction chain.

Scope and access conditions

Access to KRW1 settlement on Injective will not be open to all participants. The arrangement is restricted to approved institutional partners and remains contingent on regulatory approval in South Korea. BDACS is already a registered virtual asset service provider (VASP) in South Korea and focuses on digital-asset custody and infrastructure for institutional clients. The firm reported assets under custody exceeding 80 billion KRW in the first half of 2026.

Why Injective specifically

Injective is not a new entrant to South Korea's institutional market. The Layer 1 network was previously selected by POSCO International and LG CNS for the issuance, transfer, administration, and settlement of trade receivables tied to cross-border commerce. The network has processed more than $7.5 billion in on-chain volume and has seen more than $1 billion in tokenized assets issued on its platform, according to figures cited by the companies. That existing corporate footprint gives the KRW1 initiative a ready-made institutional distribution channel.

The Regulatory Backdrop Driving This Deal

The partnership does not exist in a vacuum. South Korea's government and national legislature have been developing the Digital Asset Basic Act, which would create a formal framework for won-denominated stablecoins. According to The Block's reporting, the bill is in its final stages of government consultation and is scheduled for discussion at the national legislature in the coming weeks.

The stablecoin outflow problem

The companies cite a striking data point to justify the initiative: South Korea's five largest crypto exchanges recorded 18 consecutive months of net stablecoin outflows to overseas platforms, totalling approximately $10.4 billion. That capital is leaving Korean markets because there is no competitive won-denominated stablecoin to retain it on domestic infrastructure. Dollar-backed stablecoins account for over 98% of global stablecoin market capitalisation, meaning virtually all stablecoin liquidity is denominated in a foreign currency from a Korean institutional perspective.

Harry Ryoo, CEO of BDACS, framed the gap plainly: without on-chain won infrastructure, tokenized-market demand stays anchored to dollar stablecoins. The KRW1 initiative is an attempt to change that equation, step by step, as Korea's regulatory framework takes shape.

Lifecycle stage: proposed, not live

It is important to be precise about what exists right now. This is an MOU, not a live product. KRW1 settlement on Injective requires regulatory approval and is limited to approved institutional counterparties. The Digital Asset Basic Act has not yet passed. Firms should treat this as an emerging development to monitor, not a live compliance obligation.

Accounting Implications for B2B Practitioners

When KRW1 does go live under a regulatory framework, it will create accounting questions that differ meaningfully from those posed by dollar stablecoins. Firms advising Korean institutions or holding tokenized assets settled in KRW1 should begin scoping these issues now.

Functional currency and foreign exchange

For a Korean entity whose functional currency is the won, a KRW1-settled position eliminates the foreign-exchange translation step that arises when settling through dollar stablecoins. That is operationally simpler and reduces the frequency of realised FX gains or losses on settlement legs. For a non-Korean entity holding KRW1, the opposite is true: the token creates a KRW-denominated monetary asset that must be retranslated at each reporting date under IAS 21 or the equivalent local GAAP, with exchange differences recognised in profit or loss.

Classification and measurement

Under IFRS 9, a fiat-pegged stablecoin held by a financial institution or corporate treasury will typically be classified as a financial asset. The classification determines whether it sits at amortised cost or fair value through profit or loss. The critical question is whether KRW1 qualifies as a cash equivalent under IAS 7, which requires the holding to be readily convertible to a known amount of cash and subject to insignificant risk of value change. Until KRW1 has demonstrated sufficient liquidity depth and regulatory standing, auditors will likely resist cash-equivalent treatment.

Custody and internal controls

BDACS provides custody for institutional clients. Accounting firms auditing clients who custody digital assets through BDACS will need to assess the adequacy of custody controls, including key management, segregation of assets, and third-party assurance reports. The institutional-only access condition means standard retail-exchange confirmations are unlikely to be available, reinforcing the need for direct custodian confirmations and, where possible, on-chain verification.

RWA tokenization accounting

The underlying use case here is settlement of tokenized real-world assets, including trade receivables of the type already processed by POSCO International and LG CNS on Injective. When a trade receivable is tokenized and settled in KRW1, the accounting must address derecognition of the original receivable, recognition of the token, and ultimately recognition of the cash received on redemption. IFRS 9's derecognition criteria and IFRS 15's revenue recognition requirements both apply, depending on whether the arrangement transfers substantially all risks and rewards or retains them.

Firms with clients in the trade finance space should be reviewing their accounting policies for tokenized receivables now, ahead of any live product launch. Robust digital asset accounting software capable of tracking token issuance, settlement, and redemption events across multiple blockchains will be essential for audit trail integrity.

AML and KYC Considerations

BDACS operates as a registered VASP in South Korea, which means it is subject to the country's Act on Reporting and Using Specified Financial Transaction Information (the "SFTIA") and the Financial Intelligence Unit's supervision. KRW1 transactions on Injective will therefore be subject to travel rule obligations on the Korean side. For non-Korean institutional counterparties transacting in KRW1, the relevant question is whether their home regulator's travel rule obligations extend to transactions settled in a foreign-jurisdiction stablecoin on a non-custodial blockchain.

Institutional-only access as a compliance design choice

Restricting KRW1 to approved institutional partners is itself a compliance design decision. It mirrors the approach taken by several regulated stablecoin issuers globally, where whitelisting reduces the pool of counterparties to those who have completed full KYC and AML checks. For compliance teams at firms onboarding to the Injective/BDACS infrastructure, this means counterparty due diligence will be done at the VASP level rather than at the individual transaction level, but firms must still satisfy themselves that BDACS's own AML controls are adequate. This connects to the broader question of how AI-assisted supervision tools are being used by regulators, a theme covered in our analysis of how VARA, the FCA, and HKMA are deploying AI in crypto oversight.

Sanctions screening in a won-denominated context

KRW1's geographic anchor to South Korea does not eliminate sanctions risk. Any blockchain-based asset can be transferred across jurisdictions. Firms must ensure that their sanctions screening processes cover KRW1 addresses and that their stablecoin compliance frameworks are not siloed by currency denomination. The obligations under OFAC, UN Security Council resolutions, and South Korea's own financial sanctions regime all apply simultaneously.

What Firms Should Do Now

Given that this partnership is at the MOU stage and the Digital Asset Basic Act has not yet passed, immediate action is about preparation rather than implementation. The specific steps differ slightly depending on the firm's role.

For accounting firms and auditors

Start by identifying which clients have existing or planned exposure to South Korean crypto markets, tokenized trade finance, or Injective-based RWA products. Update your digital asset accounting policy templates to include a section on KRW-denominated stablecoins, covering functional currency analysis, IAS 21 translation, IFRS 9 classification, and custody confirmation procedures. Consider whether your current crypto accounting software can ingest Injective chain data and map KRW1 token events to the appropriate ledger entries. If it cannot, now is the time to evaluate whether your tooling needs to expand.

For CFOs at Korean or Korea-exposed corporates

Brief your treasury and finance teams on the KRW1 initiative and the forthcoming Digital Asset Basic Act. Even if your firm has no current plans to use tokenized settlement infrastructure, your counterparties in trade finance may. Review your group accounting policy for digital assets and confirm whether your functional currency analysis has been documented at the entity level. If your firm already tokenizes receivables or plans to, engage your auditors on the derecognition and measurement treatment before the first transaction occurs, not after.

Injective and BDACS Back a Korean Won Stablecoin for RWA Settlement

Frequently Asked Questions

What is KRW1?

KRW1 is a Korean won-pegged stablecoin issued by BDACS, a registered virtual asset service provider in South Korea. Under the Injective MOU, it is designated as the exclusive won-denominated settlement asset for tokenized real-world assets on the Injective network, subject to regulatory approval.

Does this MOU create any immediate compliance obligations?

No. An MOU is a statement of intent, not a live product. KRW1 settlement on Injective requires regulatory approval and is restricted to approved institutional partners. The Digital Asset Basic Act, which would provide the legal framework, has not yet been passed by South Korea's national legislature. Firms should monitor developments rather than take immediate compliance action.

How should KRW1 holdings be classified under IFRS?

Until KRW1 has demonstrated sufficient regulatory standing and liquidity, it is unlikely to qualify as a cash equivalent under IAS 7. For non-Korean entities, it would typically be classified as a financial asset under IFRS 9, with KRW/functional currency translation required at each reporting date under IAS 21. The specific measurement category depends on the business model and contractual cash flow characteristics of the holding.

What AML obligations apply to KRW1 transactions?

BDACS is a registered VASP in South Korea and is subject to the country's SFTIA and travel rule requirements. Non-Korean counterparties must also assess whether their home jurisdiction's travel rule and sanctions obligations apply to KRW1 transactions settled on Injective. The institutional-only access model means counterparty KYC is conducted at the VASP level, but firms must independently verify the adequacy of BDACS's AML controls.

Why does the $10.4 billion stablecoin outflow figure matter to accountants?

It signals that a substantial volume of Korean crypto-market activity is being settled through overseas dollar-stablecoin infrastructure rather than domestic systems. If KRW1 successfully captures even a portion of that flow, it will change where transaction records, custody arrangements, and regulatory reporting obligations sit, all of which affect how accountants and auditors obtain evidence and prepare financial statements for Korean institutional clients.

Source: The Block

KRGLOBAL#stablecoins#tokenisationProposedAML/KYC & Licensing

Related articles

AML/KYC & Licensing
Crypto's Institutional Moment: What TradFi's Move Means for AML and Accounting Teams
AML/KYC & Licensing
Korea Joins FATF Steering Committee: AML Policy Implications
AML/KYC & Licensing
FSB Puts Stablecoin and AI Risks Before G20
AML/KYC & Licensing
FinCEN Targets A7 Network Sub-Agents in Major AML Action